LIFECOME BIOCHEMISTRY CO., LTD. — Investor Relations & Filings
Lifecome Biochemistry Co., Ltd. focuses on the research, development, and large-scale production of fermentation-based veterinary pharmaceuticals and feed additives. The company’s core product portfolio includes Bacitracin Zinc, Bacitracin Methylene Disalicylate (BMD), and Colistin Sulfate, available in both active pharmaceutical ingredient (API) and premix forms. These biochemical products are primarily utilized in the livestock and poultry sectors to manage enteric health and improve feed efficiency. The organization operates advanced fermentation and purification facilities, maintaining compliance with international Good Manufacturing Practices (GMP) and various global regulatory standards. By leveraging specialized biotechnological processes, the company provides high-purity solutions aimed at enhancing animal nutrition and disease prevention across international markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 第五届董事会第三十四次（临时）会议决议公告 | 2026-04-14 | Chinese | |
| 2026年一季度报告 | 2026-04-14 | Chinese | |
| 关于变更证券事务代表的公告 | 2026-04-14 | Chinese | |
| 2025年度股东会决议公告 | 2026-03-31 | Chinese | |
| 关于绿康生化股份有限公司2025年年度股东会的法律意见书 | 2026-03-31 | Chinese | |
| 浙商证券股份有限公司关于绿康生化股份有限公司重大资产出售暨关联交易之2025年度持续督导意见 | 2026-03-30 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 34908835 | 第五届董事会第三十四次（临时）会议决议公告 | 2026-04-14 | Chinese | ||
| 34908827 | 2026年一季度报告 | 2026-04-14 | Chinese | ||
| 34844201 | 关于变更证券事务代表的公告 | 2026-04-14 | Chinese | ||
| 38152243 | 2025年度股东会决议公告 | 2026-03-31 | Chinese | ||
| 38152240 | 关于绿康生化股份有限公司2025年年度股东会的法律意见书 | 2026-03-31 | Chinese | ||
| 38152238 | 浙商证券股份有限公司关于绿康生化股份有限公司重大资产出售暨关联交易之2025年度持续督导意见 | 2026-03-30 | Chinese | ||
| 38152237 | 关于持股5%以上股东股份减持计划实施完毕的公告 | 2026-03-30 | Chinese | ||
| 38152235 | 关于向深交所申请撤销退市风险警示及其他风险警示的进展公告 | 2026-03-30 | Chinese | ||
| 38152233 | 关于持股5%以上股东部分股份被冻结的公告 | 2026-03-11 | Chinese | ||
| 38152230 | 独立董事2025年度述职报告 （张鹏东） | 2026-03-09 | Chinese | ||
| 38152226 | 独立董事2025年度述职报告 （蔡文武） | 2026-03-09 | Chinese | ||
| 38152216 | 关于修订《公司章程》及相关制度的公告 | 2026-03-09 | Chinese | ||
| 38152206 | 关于公司2025年度拟不进行利润分配的公告 | 2026-03-09 | Chinese | ||
| 38152204 | 非经营性资金占用及其他关联资金往来情况汇总表 | 2026-03-09 | Chinese | ||
| 38152198 | 独立董事2025年度述职报告 （狄旸，已离职） | 2026-03-09 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
LIFECOME BIOCHEMISTRY CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54867/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54867 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54867 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54867 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54867}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for LIFECOME BIOCHEMISTRY CO., LTD. (id: 54867)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.